Jeroen L A van Vugt
Overview
Explore the profile of Jeroen L A van Vugt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1043
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dietz M, Popuri K, Janssen L, Salehin M, Ma D, Chow V, et al.
Nutrition
. 2024 Oct;
129:112592.
PMID: 39442384
Introduction: Body composition evaluation can be used to assess patients' nutritional status to predict clinical outcomes. To facilitate reliable and time-efficient body composition measurements eligible for clinical practice, fully automated...
2.
Sadeghirad B, Dodsworth B, Gelsomino N, Goettel N, Spence J, Buchan T, et al.
JAMA Netw Open
. 2023 Oct;
6(10):e2337239.
PMID: 37819663
Importance: Postoperative delirium (POD) is a common and serious complication after surgery. Various predisposing factors are associated with POD, but their magnitude and importance using an individual patient data (IPD)...
3.
Aramini B, Masciale V, van Vugt J
Front Oncol
. 2023 Aug;
13:1257762.
PMID: 37621685
No abstract available.
4.
Beumer B, Takagi K, Buettner S, Umeda Y, Yagi T, Fujiwara T, et al.
Int J Surg
. 2023 May;
109(8):2258-2266.
PMID: 37204461
Background: Patient fitness is important for guiding treatment. Muscle mass, as a reflection thereof, can be objectively measured. However, the role of East-West differences remains unclear. Therefore, we compared the...
5.
van Rees J, Wullaert L, Gruter A, Derraze Y, Tanis P, Verheul H, et al.
Front Oncol
. 2023 Feb;
13:1083285.
PMID: 36793616
Background: Circulating tumour DNA (ctDNA) has been established as a promising (prognostic) biomarker with the potential to personalise treatment in cancer patients. The objective of this systematic review is to...
6.
Beumer B, van Vugt J, Sapisochin G, Yoon P, Bongini M, Lu D, et al.
J Cachexia Sarcopenia Muscle
. 2023 Jan;
13(5):2373-2382.
PMID: 36622940
Background: Access to the liver transplant waitlist for patients with hepatocellular carcinoma (HCC) depends on tumour presentation, biology, and response to treatments. The Milan Criteria (MC) represent the benchmark for...
7.
van Keulen A, Gaspersz M, van Vugt J, Roos E, Olthof P, Coelen R, et al.
Surgery
. 2022 Aug;
172(6):1606-1613.
PMID: 35989132
Background: The patients with unresectable perihilar cholangiocarcinoma require biliary drainage to relieve symptoms and allow for palliative systemic chemotherapy. The aim of this study was to establish the success, complication,...
8.
Dietz M, van Kooten J, van Vugt J, Brandt-Kerkhof A, Verhoef C, Madsen E
Ann Surg Oncol
. 2022 Jun;
29(9):5830-5841.
PMID: 35650370
Background: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a potentially curative treatment for peritoneal metastases from colorectal cancer (CRC) or pseudomyxoma peritonei (PMP). Because of the considerable morbidity...
9.
Meyer Y, Galjart B, Waalboer R, Olthof P, van Vugt J, Grunhagen D, et al.
HPB (Oxford)
. 2022 May;
24(10):1711-1719.
PMID: 35550727
Background: Sarcopenia is associated with impaired short- and long-term outcomes in gastrointestinal cancers. Whether sarcopenia is associated with impaired survival after local therapy of Colorectal Cancer Liver Metastases (CRLM) remains...
10.
Aziz M, van Dongen J, Saida L, Suker M, van Vugt J, van Putten Y, et al.
Front Oncol
. 2022 Mar;
12:827755.
PMID: 35296013
Background And Aims: Failing immune surveillance in pancreatic ductal adenocarcinoma (PDAC) is related to poor prognosis. PDAC is also characterized by its substantial alterations to patients' body composition. Therefore, we...